Prenatal β-thalassemia carrier screening in Australia: Healthcare professionals' perspectives of clinical practice

Prenatal Diagnosis

Volumn 34, Issue 3, 2014, Pages 246-250

  Cousens, Nicole E ^a,b   Gaff, Clara L ^a,b,c   Delatycki, Martin B ^a,b,d   Metcalfe, Sylvia A ^a,b  

^a MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d AUSTIN HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AWARENESS; BETA THALASSEMIA; CLINICAL PRACTICE; FEMALE; GENERAL PRACTITIONER; GENETIC COUNSELOR; GENETIC SCREENING; HEALTH CARE PERSONNEL; HEALTH PERSONNEL ATTITUDE; HEMATOLOGIST; HETEROZYGOTE; HUMAN; MIDWIFE; NORMAL HUMAN; PRACTICE GUIDELINE; PRENATAL BETA THALASSEMIA CARRIER SCREENING; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; QUALITATIVE RESEARCH; VOCATIONAL EDUCATION; AUSTRALIA; BETA-THALASSEMIA; HETEROZYGOTE DETECTION; MASS SCREENING; PREGNANCY; STANDARDS;

ATTITUDE OF HEALTH PERSONNEL; BETA-THALASSEMIA; FEMALE; HETEROZYGOTE DETECTION; HUMANS; MASS SCREENING; PREGNANCY; VICTORIA;

EID: 84896731620     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4297     Document Type: Article

References (27)

1. Modell B, Darlison M. Global epidemiology of hemoglobin disorders and derived service indicators. Bull World Health Organ 2008;86(6):480-7.
2. McCabe LL, McCabe ERB. Genetic screening: carriers and affected individuals. Annu Rev Genomics Hum Genet 2004;5:57-69.
3. Norton ME. Genetic screening and counseling. Curr Opin Obstet Gynecol 2008;20(2):157-63.
4. Delatycki MB. Population screening for reproductive risk for single gene disorders in Australia: now and the future. Twin Res Hum Genet 2008;11(4):422-30.
5. Cousens NE, Gaff CL, Metcalfe SA, Delatycki MB. Carrier screening for beta-thalassemia: a review of international practice. Eur J Hum Genet 2010;18:1077-83.
6. Metcalfe SA, Barlow-Stewart K, Campbell J, Emery J. Genetics and blood: hemoglobinopathies and clotting disorders. Aust Fam Physician 2007;36(10):812-9.
7. Trent RJA. Diagnosis of the hemoglobinopathies. Clin Biochem Rev 2006;27:27-38.
8. Flander L, Fletcher A, Gertig D, Hopper J. Thalassemia screening in Victoria from a public health perspective. Department of Human Services, Victoria, 2003.
9. Routine antenatal assessment in the absence of pregnancy complications. The Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Available at: http://www.ranzcog.edu.au/component/docman/doc_view/1225-c-obs-03b-routine-antenatal-assessment-in-the-absence-of-pregnancy-complications.html?Itemid=341 [Accessed 21 November 2013].
10. Mercy Hospital for Women. Thalassemia screening protocol, Genetics Dept, Mercy Hospital for Women: Melbourne, Victoria, 2010.
11. RWH. The Royal Women's Hospital Maternity Clinical Practice Guidelines- thalassemia and abnormal hemoglobin in pregnancy, 2008. Available at: http://www.nevdgp.org.au/info/topics/maternity/Thalassaemia_Screen_p.pdf [Accessed 21 November 2013].
12. Petrou V, Bowden D. Hemoglobinopathy screening for high risk populations. Suggested protocol for targeted testing of high risk populations, Thalassaemia Services Victoria, Medical Therapy Unit, Monash Medical Centre: Melbourne, 2007.
13. Cousens NE, Metcalfe SA, Gaff CL, Delatycki MB. "He didn't say that thalassemia might come up"- β-thalassemia carriers' experiences and attitudes. J Community Genet 2013;4(2):223-32.
14. Liamputtong P, Ezzy D. Qualitative Research Methods (2nd edn). Oxford University Press: Melbourne, 2005.
15. Hsieh H, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res 2005;15(9):1277-88.
16. Elo S, Kyngas H. The qualitative content analysis process. J Adv Nurs 2008;62(1):107-15.
17. Polit DF, Beck CT. Essentials of Nursing Research. Methods, Appraisal, and Utilization (6th edn). Lippincott Williams and Wilkins: Philadelphia, Baltimore, New York, London, Buenos Aires, Hong Kong, Sydney, Tokyo, 2006.
18. Mercy Hospital for Women, The Royal Women's Hospital, Western Health and Northern Health. Guidelines for Shared Maternity Care Affiliates. Mercy Hospital for Women, The Royal Women's Hospital, Western Health and Northern Health: Melbourne, Victoria, 2010.
19. NHS. NHS sickle cell and thalassemia screening programme, 2010. Available at: http://www.sct.screening.nhs.uk [updated 2009]. http://www.sct.screening.nhs.uk.
20. Locock L, Kai J. Parents' experiences of universal screening for haemoglobin disorders: implications for practice in a new genetics era. Br J Gen Pract 2008;58:161-8.
21. Ormond KE, Iris M, Banuvar S, et al. What do patients prefer: informed consent models for genetic carrier testing. J Genet Counsel 2007;16:539-50.
22. WHO. Proposed International Guidelines on Ethical Issues in Medical Genetics and Genetic Services. World Health Organization: Geneva, 1998.
23. Delany CM. In private practice, informed consent is interpreted as providing explanations rather than offering choices: a qualitative study. Aust J Physiother 2007;53:171-7.
24. Braude H, Kimmelman J. The ethics of managing affective and emotional states to improve informed consent: autonomy, comprehension, and voluntariness. Bioethics 2012;26(3):149-56.
25. Metcalfe S. Carrier screening in preconception consultation in primary care. J Community Genet 2012;3:193-203.
26. Qureshi N, Armstrong S, Modell B. GPs' opinions of their role in prenatal genetic services: a cross-sectional survey. Fam Pract 2006;23:106-10.
27. PEGASUS: Professional Education for Genetic Assessment and Screening. Available at: http://www.pegasus.nhs.uk/.